Mortality after total pancreatectomy in an observational nationwide cohort study.
코호트
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
946 patients underwent total pancreatectomy; 7060 patients (50.
I · Intervention 중재 / 시술
total pancreatectomy; 7060 patients (50
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The mortality after total pancreatectomy differs significantly between hospitals based on nationwide administrative data across all hospitals. Further in-depth analysis of more granular data to understand the case volume-mortality relationship for total pancreatectomy is warranted.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 44.0%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[BACKGROUND] As a result of adjuvant therapies for pancreatic cancer including new techniques, such as arterial divestment, and, for instance, as a result of more main-duct intraductal papillary mucin
- p-value P < 0.001
APA
Mantke R, Weber U, et al. (2025). Mortality after total pancreatectomy in an observational nationwide cohort study.. The British journal of surgery, 112(6). https://doi.org/10.1093/bjs/znaf091
MLA
Mantke R, et al.. "Mortality after total pancreatectomy in an observational nationwide cohort study.." The British journal of surgery, vol. 112, no. 6, 2025.
PMID
40458937 ↗
Abstract 한글 요약
[BACKGROUND] As a result of adjuvant therapies for pancreatic cancer including new techniques, such as arterial divestment, and, for instance, as a result of more main-duct intraductal papillary mucinous neoplasms being diagnosed, the number of total pancreatectomies is increasing. Results of these complex operations are only available as centre analyses. The aim of this study was to analyse mortality after total pancreatectomy using real-world data.
[METHODS] An observational retrospective study based on routine data of the nationwide German diagnosis-related group (DRG) statistics was performed. All total pancreatectomies from 2010 to 2020 were analysed and classified into four types. Univariable and multivariable analyses were performed for in-hospital mortality as the endpoint.
[RESULTS] During the study interval, 13 946 patients underwent total pancreatectomy; 7060 patients (50.6%) underwent type 1 standard total pancreatectomy, 1682 patients (12.1%) underwent type 2 total pancreatectomy (included venous procedures), 3921 patients (28.1%) underwent type 3 total pancreatectomy (included multivisceral resections), and 1283 patients (9.2%) underwent type 4 total pancreatectomy (included arterial procedures). Relaparotomy was necessary for 3232 patients (23.2%). Overall, the in-hospital mortality rate was 22.0% (3072 patients), which varied depending on the type of total pancreatectomy (type 1, 15.6% (1102 patients); type 2, 17.2% (290 patients); type 3, 31.5% (1235 patients); and type 4, 34.7% (445 patients); P < 0.001). The worst outcome of 60.7% in-hospital mortality was related to a small subgroup of 56 patients who were operated on in hospitals that performed one to ten type 4 total pancreatectomies in 2010-2020. With increasing caseload, in-hospital mortality significantly decreased (P < 0.001) for all resection types.
[CONCLUSION] The mortality after total pancreatectomy differs significantly between hospitals based on nationwide administrative data across all hospitals. Further in-depth analysis of more granular data to understand the case volume-mortality relationship for total pancreatectomy is warranted.
[METHODS] An observational retrospective study based on routine data of the nationwide German diagnosis-related group (DRG) statistics was performed. All total pancreatectomies from 2010 to 2020 were analysed and classified into four types. Univariable and multivariable analyses were performed for in-hospital mortality as the endpoint.
[RESULTS] During the study interval, 13 946 patients underwent total pancreatectomy; 7060 patients (50.6%) underwent type 1 standard total pancreatectomy, 1682 patients (12.1%) underwent type 2 total pancreatectomy (included venous procedures), 3921 patients (28.1%) underwent type 3 total pancreatectomy (included multivisceral resections), and 1283 patients (9.2%) underwent type 4 total pancreatectomy (included arterial procedures). Relaparotomy was necessary for 3232 patients (23.2%). Overall, the in-hospital mortality rate was 22.0% (3072 patients), which varied depending on the type of total pancreatectomy (type 1, 15.6% (1102 patients); type 2, 17.2% (290 patients); type 3, 31.5% (1235 patients); and type 4, 34.7% (445 patients); P < 0.001). The worst outcome of 60.7% in-hospital mortality was related to a small subgroup of 56 patients who were operated on in hospitals that performed one to ten type 4 total pancreatectomies in 2010-2020. With increasing caseload, in-hospital mortality significantly decreased (P < 0.001) for all resection types.
[CONCLUSION] The mortality after total pancreatectomy differs significantly between hospitals based on nationwide administrative data across all hospitals. Further in-depth analysis of more granular data to understand the case volume-mortality relationship for total pancreatectomy is warranted.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.